The growth of breast reconstruction market is attributed to the rising prevalence of breast cancer. For instance, according the Breastcancer.org, in the U.S., nearly 266,120 new cases of invasive breast cancer are expected to be diagnosed in women along with 63,960 new cases of non-invasive breast cancer in 2018. However, breast reconstruction procedures involve a large number of complications. Most common complication associated with silicone and saline breast reconstruction are capsular contracture, reoperation, implant removal, and rupture or deflation of the implant. In addition to the complications, low awareness among populace coupled with high cost of surgical procedures are expected to restrain the growth of the market during the forecast period. According to the American Society of Plastic Surgeons (ASPS) 2017, less than half of the women that requires mastectomy are currently offered breast reconstruction surgery in the U.S. due to unawareness of healthcare providers and patients.
